| Current Price | $14.24 | Mkt Cap | $1.8B |
|---|---|---|---|
| Open | $14.14 | P/E Ratio | 19.76 |
| Prev. Close | $14.24 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $14.10 - $14.49 | Volume | 1,637,170 |
| 52-Wk Range | $9.42 - $15.12 | Avg. Daily Vol. | 1,718,107 |
A biopharmaceutical company that discovers and develops Toll-like Receptor 9 and agonist-based products to treat and prevent infectious diseases, allergies, cancer and chronic inflammatory.
| Current Price | $14.24 | Mkt Cap | $1.8B |
|---|---|---|---|
| Open | $14.14 | P/E Ratio | 19.76 |
| Prev. Close | $14.24 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $14.10 - $14.49 | Volume | 1,637,170 |
| 52-Wk Range | $9.42 - $15.12 | Avg. Daily Vol. | 1,718,107 |
The best Bull and Bear pitches based on recency and number of recommendations.
The zzporte portfolio ate a large helping of dirt today with the announcement of the CRL for Heplisav. The CRL wasn't an enormous surprise, given the tortuous history of Heplisav and the cancellation of the Ad Comm. I probably wouldn't have bought… More
Read the most recent pitches from players about DVAX.
Recs
TMFGBudwell
(< 20)
Submitted: 12/18/2017 4:17:46 AM :
Start Price:
$19.40
NASDAQ:DVAX Score:
-85.45
Undervalued from a long-term growth perspective.
Recs
Patastic
(< 20)
Submitted: 8/9/2017 4:52:28 PM :
Start Price:
$16.25
NASDAQ:DVAX Score:
-84.47
Heplisav Approval almost a lock. SD-101 shows great promise in combination with Keytruda (100% ORR). New lung cancer inhalable TLR agonist in combo with anti PD-1 going into trials this quarter. Partnership with AstraZeneca on a cure for asthma...Holy cow. I'm in long on this one.
Recs
rocknrook
(48.82)
Submitted: 1/19/2017 12:20:50 PM :
Start Price:
$4.30
NASDAQ:DVAX Score:
+143.01
I think management is finally getting their act together on approval process. Hep drug should approve soon & other potentials in the pipeline. Once Hep comes through, I expect a large pop in value.
Find the members with the highest scoring picks in DVAX.
mavimadero (< 20) Score: +315.66
The Score Leader is the player with the highest score across all their picks in DVAX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| Playa14 | < 20 | 7/31/2019 |
|
5Y | $2.87 | +396.17% | +41.54% | +354.63 | 0 Comment | |
| mavimadero | < 20 | 10/9/2006 |
|
3W | $72.90 | -80.47% | +235.20% | +315.66 | 0 Comment | |
| hawkider | < 20 | 12/8/2006 |
|
3Y | $95.20 | -85.04% | +220.36% | +305.40 | 1 Comment | |
| HondurasAlan | 67.46 | 1/8/2007 |
|
3W | $61.40 | -76.81% | +219.99% | +296.80 | 0 Comment | |
| Turkmenbashi | 62.95 | 1/8/2007 |
|
NS | $59.70 | -76.15% | +220.23% | +296.37 | 0 Comment | |
| dozer963 | 55.75 | 3/18/2008 |
|
NS | $23.00 | -38.09% | +237.91% | +276.00 | 0 Comment | |
| cthomas1017 | 98.72 | 12/7/2012 |
|
5Y | $26.05 | -45.34% | +198.80% | +244.14 | 0 Comment | |
| rqtect | < 20 | 2/27/2013 |
|
3W | $21.00 | -32.19% | +184.13% | +216.32 | 0 Comment | |
| tempttempt | 75.73 | 7/17/2019 |
|
5Y | $4.03 | +253.35% | +41.71% | +211.64 | 0 Comment | |
| stereotyp72 | 64.61 | 11/23/2020 |
|
5Y | $4.36 | +226.61% | +19.22% | +207.38 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
